M&A Deal Summary

Pfizer Acquires Icagen

On July 19, 2011, Pfizer acquired life science company Icagen for 56M USD

Acquisition Highlights
  • This is Pfizer’s 14th transaction in the Life Science sector.
  • This is Pfizer’s 21st largest (disclosed) transaction.
  • This is Pfizer’s 14th transaction in the United States.
  • This is Pfizer’s 2nd transaction in North Carolina.

M&A Deal Summary
Date 2011-07-19
Target Icagen
Sector Life Science
Buyer(s) Pfizer
Deal Type Add-on Acquisition
Deal Value 56M USD
Advisor(s) J.P. Morgan Securities (Financial)

Target

Icagen

Durham, North Carolina, United States
Icagen, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Pfizer

New York, New York, United States
Category Company
Founded 1849
Sector Life Science
Employees8,300
Revenue 58.5B USD (2023)
DESCRIPTION
Pfizer office in Lake Forest, Illinois.
Pfizer office in Lake Forest, Illinois.

Pfizer is a global pharmaceutical company that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare products, including medicines and vaccines. The company's portfolio includes treatments across a broad spectrum of areas such as oncology, cardiology, neurology, and infectious diseases, among others. Pfizer was founded in 1849 and is based in New York, New York.

DEAL STATS #
Overall 16 of 43
Sector (Life Science) 14 of 39
Type (Add-on Acquisition) 14 of 31
State (North Carolina) 2 of 3
Country (United States) 14 of 31
Year (2011) 3 of 5
Size (of disclosed) 21 of 21
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-04-04 Capsugel Belgium NV

Colmar, France

Capsugel Belgium NV is a provider of hard capsules and an innovator in drug delivery systems for the pharmaceutical, OTC and health and nutrition industries. Capsugel offers a comprehensive array of products and services, from hard gelatin, vegetarian and liquid-filled capsules, to innovative R&D equipment and liquid formulations as part of its Licaps Drug Delivery System.

Sell $2.4B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-09-13 AM-Pharma

Utrecht, Netherlands

AM-Pharma is a biopharmaceutical company developing a biotherapeutic for the treatment of Acute Kidney Injury. The company initiated a 290 patient phase 2 study of recombinant human Alkaline Phosphatase in Acute Kidney Injury. AM-Pharma was founded in 2000 and is based in Utrecht, Netherlands.

Buy -
Mergr

Product

Company

Legal